Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Stroke is a medical condition caused due to a poor flow of blood to the brain. They are classified into ischemic and hemorrhagic, ischemic occur due to lack of supply of blood and hemorrhagic occur due to bleeding, in both cases brain does not work properly. Inability to move or feel on one side of the body, problems in speaking or understanding, dizziness, or loss of vision to one side are some of the symptoms of a stroke. It is one of the major causes of death and mostly occurs in the old age population. However, with the advancement in medical science, there are various treatments available to prevent deaths from strokes.
Rising cases of hypertension, atrial fibrillation, and coronary heart diseases leading to the increasing rate of stroke, which is expected to fuel the market growth of stroke diagnostics and therapeutics. According to the World Health Organization, 15 million people suffer strokes worldwide each year. Of these, 5 million dies and another 5 million are permanently disabled. Moreover, high blood pressure contributes to more than 12.7 million strokes worldwide.
From the geographical perspective, North America is expected to gain significant growth over the forecast period and this can be attributed to the rising number of stroke-related death cases in the region. According to the WHO, stroke is the third leading cause of death in the United States. More than 140,000 people die each year from stroke in the United States. Moreover, rising spending by the U.S government in the healthcare sector for improving the facilities and reducing the fatalities rate is further expected to boost the regional market growth. According to the report published by Research America, Investment in medical and health research and development (R&D) in the U.S. grew by 13.3% from 2013 to 2015. The industry invested more than any other sector, representing 64.7% of total spending in 2015, followed by the federal government at 22.6%.
Key Developments:
-- In July 2019, MedCity and Stroke Association have entered into a collaboration to identify and support the development of digital health therapeutics and medical devices for patients living with the long-term health impact of stroke.
-- In May 2017, Brainomix and Boehringer Ingelheim collaborated for developing new technology that could dramatically shorten the diagnosis time of stroke patients. Brainomix team developed the rapid digital analysis of scans of patients admitted to the hospital with a stroke. The e-ASPECTS software acts as a standardized and rapid second-opinion tool that assists physicians on-site to choose an appropriate treatment based on the magnitude and nature of the brain damage.
-- In December 2016, researchers in Europe develop a new hybrid device that combines different imaging technologies and help stroke patients in particular to receive quicker diagnosis and treatment. The project "Predictive Prevention and Personalized Interventional Stroke Therapy - P3 Stroke" is being undertaken by the University of Erlangen-Nuremberg (FAU), in collaboration with Siemens Healthcare GmbH, Universitätsklinikum Erlangen and other European partners.
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Abbott Laboratories
Cordis Corporation
Boston Scientific Corporation
Siemens AG
Genentech
Koninklijke Philips N.V
Medtronic plc
GE Healthcare
Stryker Corporation
Merck & Co.,Inc
By types, the market can be split into
Diagnostics
Therapeutics
By Application, the market can be split into
Ischemic Stroke
Haemorrhagic Stroke
Other
By Regions, this report covers (we can add the regions/countries as you want)
North America
China
Europe
Southeast Asia
Japan
India
Table of Contents
Global Stroke Diagnostics and Therapeutics Market Professional Survey Report 2019
1 Industry Overview of Stroke Diagnostics and Therapeutics
1.1 Definition and Specifications of Stroke Diagnostics and Therapeutics
1.1.1 Definition of Stroke Diagnostics and Therapeutics
1.1.2 Specifications of Stroke Diagnostics and Therapeutics
1.2 Classification of Stroke Diagnostics and Therapeutics
1.2.1 Diagnostics
1.2.2 Therapeutics
1.3 Applications of Stroke Diagnostics and Therapeutics
1.3.1 Ischemic Stroke
1.3.2 Haemorrhagic Stroke
1.3.3 Other
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
2 Manufacturing Cost Structure Analysis of Stroke Diagnostics and Therapeutics
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Stroke Diagnostics and Therapeutics
2.3 Manufacturing Process Analysis of Stroke Diagnostics and Therapeutics
2.4 Industry Chain Structure of Stroke Diagnostics and Therapeutics
3 Technical Data and Manufacturing Plants Analysis of Stroke Diagnostics and Therapeutics
3.1 Capacity and Commercial Production Date of Global Stroke Diagnostics and Therapeutics Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Stroke Diagnostics and Therapeutics Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Stroke Diagnostics and Therapeutics Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Stroke Diagnostics and Therapeutics Major Manufacturers in 2016
4 Global Stroke Diagnostics and Therapeutics Overall Market Overview
4.1 2014-2019E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2014-2019E Global Stroke Diagnostics and Therapeutics Capacity and Growth Rate Analysis
4.2.2 2016 Stroke Diagnostics and Therapeutics Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2014-2019E Global Stroke Diagnostics and Therapeutics Sales and Growth Rate Analysis
4.3.2 2016 Stroke Diagnostics and Therapeutics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2014-2019E Global Stroke Diagnostics and Therapeutics Sales Price
4.4.2 2016 Stroke Diagnostics and Therapeutics Sales Price Analysis (Company Segment)
5 Stroke Diagnostics and Therapeutics Regional Market Analysis
5.1 North America Stroke Diagnostics and Therapeutics Market Analysis
5.1.1 North America Stroke Diagnostics and Therapeutics Market Overview
5.1.2 North America 2014-2019E Stroke Diagnostics and Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2014-2019E Stroke Diagnostics and Therapeutics Sales Price Analysis
5.1.4 North America 2016 Stroke Diagnostics and Therapeutics Market Share Analysis
5.2 China Stroke Diagnostics and Therapeutics Market Analysis
5.2.1 China Stroke Diagnostics and Therapeutics Market Overview
5.2.2 China 2014-2019E Stroke Diagnostics and Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2014-2019E Stroke Diagnostics and Therapeutics Sales Price Analysis
5.2.4 China 2016 Stroke Diagnostics and Therapeutics Market Share Analysis
5.3 Europe Stroke Diagnostics and Therapeutics Market Analysis
5.3.1 Europe Stroke Diagnostics and Therapeutics Market Overview
5.3.2 Europe 2014-2019E Stroke Diagnostics and Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Europe 2014-2019E Stroke Diagnostics and Therapeutics Sales Price Analysis
5.3.4 Europe 2016 Stroke Diagnostics and Therapeutics Market Share Analysis
5.4 Southeast Asia Stroke Diagnostics and Therapeutics Market Analysis
5.4.1 Southeast Asia Stroke Diagnostics and Therapeutics Market Overview
5.4.2 Southeast Asia 2014-2019E Stroke Diagnostics and Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Southeast Asia 2014-2019E Stroke Diagnostics and Therapeutics Sales Price Analysis
5.4.4 Southeast Asia 2016 Stroke Diagnostics and Therapeutics Market Share Analysis
5.5 Japan Stroke Diagnostics and Therapeutics Market Analysis
5.5.1 Japan Stroke Diagnostics and Therapeutics Market Overview
5.5.2 Japan 2014-2019E Stroke Diagnostics and Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Japan 2014-2019E Stroke Diagnostics and Therapeutics Sales Price Analysis
5.5.4 Japan 2016 Stroke Diagnostics and Therapeutics Market Share Analysis
5.6 India Stroke Diagnostics and Therapeutics Market Analysis
5.6.1 India Stroke Diagnostics and Therapeutics Market Overview
5.6.2 India 2014-2019E Stroke Diagnostics and Therapeutics Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2014-2019E Stroke Diagnostics and Therapeutics Sales Price Analysis
5.6.4 India 2016 Stroke Diagnostics and Therapeutics Market Share Analysis
6 Global 2014-2019E Stroke Diagnostics and Therapeutics Segment Market Analysis (by Type)
6.1 Global 2014-2019E Stroke Diagnostics and Therapeutics Sales by Type
6.2 Different Types of Stroke Diagnostics and Therapeutics Product Interview Price Analysis
6.3 Different Types of Stroke Diagnostics and Therapeutics Product Driving Factors Analysis
6.3.1 Diagnostics of Stroke Diagnostics and Therapeutics Growth Driving Factor Analysis
6.3.2 Therapeutics of Stroke Diagnostics and Therapeutics Growth Driving Factor Analysis
7 Global 2014-2019E Stroke Diagnostics and Therapeutics Segment Market Analysis (by Application)
7.1 Global 2014-2019E Stroke Diagnostics and Therapeutics Consumption by Application
7.2 Different Application of Stroke Diagnostics and Therapeutics Product Interview Price Analysis
7.3 Different Application of Stroke Diagnostics and Therapeutics Product Driving Factors Analysis
7.3.1 Ischemic Stroke of Stroke Diagnostics and Therapeutics Growth Driving Factor Analysis
7.3.2 Haemorrhagic Stroke of Stroke Diagnostics and Therapeutics Growth Driving Factor Analysis
7.3.3 Other of Stroke Diagnostics and Therapeutics Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Stroke Diagnostics and Therapeutics
8.1 Abbott Laboratories
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Abbott Laboratories 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Abbott Laboratories 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.2 Cordis Corporation
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Cordis Corporation 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Cordis Corporation 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Boston Scientific Corporation 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Boston Scientific Corporation 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.4 Siemens AG
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Siemens AG 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Siemens AG 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.5 Genentech
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Genentech 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Genentech 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.6 Koninklijke Philips N.V
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Koninklijke Philips N.V 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Koninklijke Philips N.V 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.7 Medtronic plc
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Medtronic plc 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Medtronic plc 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.8 GE Healthcare
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 GE Healthcare 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 GE Healthcare 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.9 Stryker Corporation
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Stryker Corporation 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Stryker Corporation 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
8.10 Merck & Co.,Inc
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 Merck & Co.,Inc 2016 Stroke Diagnostics and Therapeutics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Merck & Co.,Inc 2016 Stroke Diagnostics and Therapeutics Business Region Distribution Analysis
9 Development Trend of Analysis of Stroke Diagnostics and Therapeutics Market
9.1 Global Stroke Diagnostics and Therapeutics Market Trend Analysis
9.1.1 Global 2019-2022 Stroke Diagnostics and Therapeutics Market Size (Volume and Value) Forecast
9.1.2 Global 2019-2022 Stroke Diagnostics and Therapeutics Sales Price Forecast
9.2 Stroke Diagnostics and Therapeutics Regional Market Trend
9.2.1 North America 2019-2022 Stroke Diagnostics and Therapeutics Consumption Forecast
9.2.2 China 2019-2022 Stroke Diagnostics and Therapeutics Consumption Forecast
9.2.3 Europe 2019-2022 Stroke Diagnostics and Therapeutics Consumption Forecast
9.2.4 Southeast Asia 2019-2022 Stroke Diagnostics and Therapeutics Consumption Forecast
9.2.5 Japan 2019-2022 Stroke Diagnostics and Therapeutics Consumption Forecast
9.2.6 India 2019-2022 Stroke Diagnostics and Therapeutics Consumption Forecast
9.3 Stroke Diagnostics and Therapeutics Market Trend (Product Type)
9.4 Stroke Diagnostics and Therapeutics Market Trend (Application)
10 Stroke Diagnostics and Therapeutics Marketing Type Analysis
10.1 Stroke Diagnostics and Therapeutics Regional Marketing Type Analysis
10.2 Stroke Diagnostics and Therapeutics International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Stroke Diagnostics and Therapeutics by Region
10.4 Stroke Diagnostics and Therapeutics Supply Chain Analysis
11 Consumers Analysis of Stroke Diagnostics and Therapeutics
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 Conclusion of the Global Stroke Diagnostics and Therapeutics Market Professional Survey Report 2019
Methodology
Analyst Introduction
Data Source
